{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T21:39:30Z","timestamp":1780695570872,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00223-009-9216-z","type":"journal-article","created":{"date-parts":[[2009,2,16]],"date-time":"2009-02-16T09:56:49Z","timestamp":1234778209000},"page":"313-323","source":"Crossref","is-referenced-by-count":33,"title":["Effects of Tumor-Induced Osteomalacia on the Bone Mineralization Process"],"prefix":"10.1007","volume":"84","author":[{"given":"K.","family":"Nawrot-Wawrzyniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Roschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sieghart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Zwettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. M.","family":"Roetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Weinkamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Klaushofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fratzl-Zelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,14]]},"reference":[{"key":"9216_CR1","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:6500\u20136505","journal-title":"Proc Natl Acad Sci USA"},{"key":"9216_CR2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"9216_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9343(84)90112-8","volume":"77","author":"EA Ryan","year":"1984","unstructured":"Ryan EA, Reiss E (1984) Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases. Am J Med 77:501\u2013512","journal-title":"Am J Med"},{"key":"9216_CR4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"SM Jan de Beur","year":"2005","unstructured":"Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294:1260\u20131267","journal-title":"JAMA"},{"key":"9216_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1210\/er.2005-0019","volume":"27","author":"KE White","year":"2006","unstructured":"White KE, Larsson TE, Econs MJ (2006) The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 27:221\u2013241","journal-title":"Endocr Rev"},{"key":"9216_CR6","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","volume":"18","author":"S Liu","year":"2007","unstructured":"Liu S, Quarles LD (2007) How fibroblast growth factor 23 works. J Am Soc Nephrol 18:1637\u20131647","journal-title":"J Am Soc Nephrol"},{"key":"9216_CR7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2169\/internalmedicine.47.0730","volume":"47","author":"S Fukumoto","year":"2008","unstructured":"Fukumoto S (2008) Physiological regulation and disorders of phosphate metabolism-pivotal role of fibroblast growth factor 23. Intern Med 47:337\u2013343","journal-title":"Intern Med"},{"key":"9216_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1010006811394","volume":"2","author":"MK Drezner","year":"2001","unstructured":"Drezner MK (2001) Tumor-induced osteomalacia. Rev Endocr Metab Disord 2:175\u2013186","journal-title":"Rev Endocr Metab Disord"},{"key":"9216_CR9","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"J Seufert","year":"2001","unstructured":"Seufert J, Ebert K, Muller J, Eulert J, Hendrich C, Werner E, Schuuze N, Schulz G, Kenn W, Richtmann H, Palitzsch KD, Jakob F (2001) Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345:1883\u20131888","journal-title":"N Engl J Med"},{"key":"9216_CR10","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87:4957\u20134960","journal-title":"J Clin Endocrinol Metab"},{"key":"9216_CR11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2169\/internalmedicine.47.0745","volume":"47","author":"T Nasu","year":"2008","unstructured":"Nasu T, Kurisu S, Matsuno S, Tatsumi K, Kakimoto T, Kobayashi M, Nakano Y, Wakasaki H, Furuta H, Nishi M, Sasaki H, Suzuki H, Ito N, Fukumoto S, Nanjo K (2008) Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23. Intern Med 47:957\u2013961","journal-title":"Intern Med"},{"key":"9216_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-07-0485","volume":"158","author":"FM Hannan","year":"2008","unstructured":"Hannan FM, Athanasou NA, Teh J, Gibbons CL, Shine B, Thakker RV (2008) Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23,1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. Eur J Endocrinol 158:265\u2013271","journal-title":"Eur J Endocrinol"},{"key":"9216_CR13","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","volume":"145","author":"X Bai","year":"2004","unstructured":"Bai X, Miao D, Li J, Goltzman D, Karaplis AC (2004) Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders. Endocrinology 145:5269\u20135279","journal-title":"Endocrinology"},{"key":"9216_CR14","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","volume":"145","author":"T Larsson","year":"2004","unstructured":"Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H, Jonsson KB (2004) Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 145:3087\u20133094","journal-title":"Endocrinology"},{"key":"9216_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","volume":"314","author":"T Shimada","year":"2004","unstructured":"Shimada T, Urakawa I, Yamazaki Y, Hasegawa H, Hino R, Yoneya T, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2004) FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314:409\u2013414","journal-title":"Biochem Biophys Res Commun"},{"key":"9216_CR16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561\u2013568","journal-title":"J Clin Invest"},{"key":"9216_CR17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421\u2013432","journal-title":"Matrix Biol"},{"key":"9216_CR18","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","volume":"291","author":"S Liu","year":"2006","unstructured":"Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD (2006) Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 291:E38\u2013E49","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9216_CR19","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2353\/ajpath.2006.060329","volume":"169","author":"D Sitara","year":"2006","unstructured":"Sitara D, Razzaque MS, St-Arnaud R, Huang W, Taguchi T, Erben RG, Lanske B (2006) Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169:2161\u20132170","journal-title":"Am J Pathol"},{"key":"9216_CR20","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1681\/ASN.2006121385","volume":"18","author":"JR Stubbs","year":"2007","unstructured":"Stubbs JR, Liu S, Tang W, Zhou J, Wang Y, Yao X, Quarles LD (2007) Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 18:2116\u20132124","journal-title":"J Am Soc Nephrol"},{"key":"9216_CR21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gad.1276205","volume":"19","author":"M Murshed","year":"2005","unstructured":"Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G (2005) Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19:1093\u20131104","journal-title":"Genes Dev"},{"key":"9216_CR22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","volume":"22","author":"JL Geller","year":"2007","unstructured":"Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT (2007) Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res 22:931\u2013937","journal-title":"J Bone Miner Res"},{"key":"9216_CR23","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1359\/jbmr.070709","volume":"22","author":"T Hayashibara","year":"2007","unstructured":"Hayashibara T, Hiraga T, Sugita A, Wang L, Hata K, Ooshima T, Yoneda T (2007) Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions. J Bone Miner Res 22:1743\u20131751","journal-title":"J Bone Miner Res"},{"key":"9216_CR24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang H, Yoshiko Y, Yamamoto R, Minamizaki T, Kozai K, Tanne K, Aubin JE, Maeda N (2008) Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23:939\u2013948","journal-title":"J Bone Miner Res"},{"key":"9216_CR25","doi-asserted-by":"crossref","first-page":"e1000154","DOI":"10.1371\/journal.pgen.1000154","volume":"4","author":"D Sitara","year":"2008","unstructured":"Sitara D, Kim S, Razzaque MS, Bergwitz C, Taguchi T, Schuler C, Erben RG, Lanske B (2008) Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet 4:e1000154","journal-title":"PLoS Genet"},{"key":"9216_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","volume":"12","author":"AM Parfitt","year":"2003","unstructured":"Parfitt AM (2003) Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 12:387\u2013403","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"9216_CR27","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bone.2007.01.012","volume":"40","author":"D Ruffoni","year":"2007","unstructured":"Ruffoni D, Fratzl P, Roschger P, Klaushofer K, Weinkamer R (2007) The bone mineralization density distribution as a fingerprint of the mineralization process. Bone 40:1308\u20131319","journal-title":"Bone"},{"key":"9216_CR28","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1359\/jbmr.080711","volume":"23","author":"D Ruffoni","year":"2008","unstructured":"Ruffoni D, Fratzl P, Roschger P, Phipps R, Klaushofer K, Weinkamer R (2008) The effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. J Bone Miner Res 23:1905\u20131914","journal-title":"J Bone Miner Res"},{"key":"9216_CR29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S8756-3282(02)00973-0","volume":"32","author":"P Roschger","year":"2003","unstructured":"Roschger P, Gupta HS, Berzlanovich A, Ittner G, Dempster DW, Fratzl P, Cosman F, Parisien M, Lindsay R, Nieves JW, Klaushofer K (2003) Constant mineralization density distribution in cancellous human bone. Bone 32:316\u2013323","journal-title":"Bone"},{"key":"9216_CR30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bone.2007.10.021","volume":"42","author":"P Roschger","year":"2008","unstructured":"Roschger P, Paschalis EP, Fratzl P, Klaushofer K (2008) Bone mineralization density distribution in health and disease. Bone 42:456\u2013466","journal-title":"Bone"},{"key":"9216_CR31","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"9216_CR32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S8756-3282(98)00112-4","volume":"23","author":"P Roschger","year":"1998","unstructured":"Roschger P, Fratzl P, Eschberger J, Klaushofer K (1998) Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 23:319\u2013326","journal-title":"Bone"},{"key":"9216_CR33","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000101487","volume":"106","author":"KM Roetzer","year":"2007","unstructured":"Roetzer KM, Varga F, Zwettler E, Nawrot-Wawrzyniak K, Haller J, Forster E, Klaushofer K (2007) Novel PHEX mutation associated with hypophosphatemic rickets. Nephron Physiol 106:8\u201312","journal-title":"Nephron Physiol"},{"key":"9216_CR34","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"KE White","year":"2001","unstructured":"White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ (2001) The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497\u2013500","journal-title":"J Clin Endocrinol Metab"},{"key":"9216_CR35","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bone.2004.08.009","volume":"35","author":"B Bielesz","year":"2004","unstructured":"Bielesz B, Klaushofer K, Oberbauer R (2004) Renal phosphate loss in hereditary and acquired disorders of bone mineralization. Bone 35:1229\u20131239","journal-title":"Bone"},{"key":"9216_CR36","first-page":"345","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"SM Jan de Beur","year":"2006","unstructured":"Jan de Beur SM (2006) Tumor-induced osteomalacia. In: Favus M (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society of Bone and Mineral Research, Washington, DC, pp 345\u2013351"},{"key":"9216_CR37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00774-005-0625-4","volume":"23","author":"N Ito","year":"2005","unstructured":"Ito N, Fukumoto S, Takeuchi Y, Yasuda T, Hasegawa Y, Takemoto F, Tajima T, Dobashi K, Yamazaki Y, Yamashita T, Fujita T (2005) Comparison of two assays for fibroblast growth factor (FGF)-23. J Bone Miner Metab 23:435\u2013440","journal-title":"J Bone Miner Metab"},{"key":"9216_CR38","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1210\/jc.2006-2865","volume":"92","author":"A Khosravi","year":"2007","unstructured":"Khosravi A, Cutler CM, Kelly MH, Chang R, Royal RE, Sherry RM, Wodajo FM, Fedarko NS, Collins MT (2007) Determination of the elimination half-life of fibroblast growth factor-23. J Clin Endocrinol Metab 92:2374\u20132377","journal-title":"J Clin Endocrinol Metab"},{"key":"9216_CR39","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2004-0406","volume":"89","author":"Y Takeuchi","year":"2004","unstructured":"Takeuchi Y, Suzuki H, Ogura S, Imai R, Yamazaki Y, Yamashita T, Miyamoto Y, Okazaki H, Nakamura K, Nakahara K, Fukumoto S, Fujita T (2004) Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia. J Clin Endocrinol Metab 89:3979\u20133982","journal-title":"J Clin Endocrinol Metab"},{"key":"9216_CR40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.070107","volume":"22","author":"EA Imel","year":"2007","unstructured":"Imel EA, Hui SL, Econs MJ (2007) FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets. J Bone Miner Res 22:520\u2013526","journal-title":"J Bone Miner Res"},{"key":"9216_CR41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","volume":"18","author":"TJ Weber","year":"2003","unstructured":"Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18:1227\u20131234","journal-title":"J Bone Miner Res"},{"key":"9216_CR42","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91:2055\u20132061","journal-title":"J Clin Endocrinol Metab"},{"key":"9216_CR43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-07-0534","volume":"158","author":"R Marsell","year":"2008","unstructured":"Marsell R, Grundberg E, Krajisnik T, Mallmin H, Karlsson M, Mellstrom D, Orwoll E, Ohlsson C, Jonsson KB, Ljunggren O, Larsson TE (2008) Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. Eur J Endocrinol 158:125\u2013129","journal-title":"Eur J Endocrinol"},{"key":"9216_CR44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.0.1480269","volume":"148","author":"T Larsson","year":"2003","unstructured":"Larsson T, Zahradnik R, Lavigne J, Ljunggren O, Juppner H, Jonsson KB (2003) Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia. Eur J Endocrinol 148:269\u2013276","journal-title":"Eur J Endocrinol"},{"key":"9216_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O\u2019Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28:1\u201330","journal-title":"Am J Surg Pathol"},{"key":"9216_CR46","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683\u2013692","journal-title":"J Clin Invest"},{"key":"9216_CR47","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","volume":"78","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Koshiyama H, Miyauchi A, Wakasa K, Kawata T, Goto H, Ohashi H, Koyano HM, Mochizuki R, Miki T, Inaba M, Nishizawa Y (2006) Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 78:2295\u20132301","journal-title":"Life Sci"},{"key":"9216_CR48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/eje.1.02053","volume":"154","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Miyauchi A, Onoda N, Kawata T, Tahara H, Goto H, Miki T, Ishimura E, Sugimoto T, Ishikawa T, Inaba M, Nishizawa Y (2006) Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol 154:93\u201399","journal-title":"Eur J Endocrinol"},{"key":"9216_CR49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000403279","volume":"18","author":"B Krempien","year":"1980","unstructured":"Krempien B, Ritz E, Tschope W (1980) The effect of 1,25 (OH)2D3 on bone mineralization: ultrastructural studies in patients with renal osteodystrophy. Contrib Nephrol 18:122\u2013134","journal-title":"Contrib Nephrol"},{"key":"9216_CR50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1210\/jcem-70-4-930","volume":"70","author":"M Parisien","year":"1990","unstructured":"Parisien M, Silverberg SJ, Shane E, de la Cruz L, Lindsay R, Bilezikian JP, Dempster DW (1990) The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab 70:930\u2013938","journal-title":"J Clin Endocrinol Metab"},{"key":"9216_CR51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.bone.2008.01.019","volume":"42","author":"K Hollberg","year":"2008","unstructured":"Hollberg K, Marsell R, Norgard M, Larsson T, Jonsson KB, Andersson G (2008) Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice. Bone 42:1111\u20131121","journal-title":"Bone"},{"key":"9216_CR52","first-page":"E700","volume":"275","author":"ZS Xiao","year":"1998","unstructured":"Xiao ZS, Crenshaw M, Guo R, Nesbitt T, Drezner MK, Quarles LD (1998) Intrinsic mineralization defect in Hyp mouse osteoblasts. Am J Physiol 275:E700\u2013E708","journal-title":"Am J Physiol"},{"key":"9216_CR53","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","volume":"88","author":"BM Misof","year":"2003","unstructured":"Misof BM, Roschger P, Cosman F, Kurland ES, Tesch W, Messmer P, Dempster DW, Nieves J, Shane E, Fratzl P, Klaushofer K, Bilezikian J, Lindsay R (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150\u20131156","journal-title":"J Clin Endocrinol Metab"},{"key":"9216_CR54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1359\/jbmr.070120","volume":"22","author":"P Roschger","year":"2007","unstructured":"Roschger P, Dempster DW, Zhou H, Paschalis EP, Silverberg SJ, Shane E, Bilezikian JP, Klaushofer K (2007) New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging. J Bone Miner Res 22:717\u2013723","journal-title":"J Bone Miner Res"},{"key":"9216_CR55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S8756-3282(97)00018-5","volume":"20","author":"P Roschger","year":"1997","unstructured":"Roschger P, Fratzl P, Klaushofer K, Rodan G (1997) Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs. Bone 20:393\u2013397","journal-title":"Bone"},{"key":"9216_CR56","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1359\/jbmr.060401","volume":"21","author":"R Zoehrer","year":"2006","unstructured":"Zoehrer R, Roschger P, Paschalis EP, Hofstaetter JG, Durchschlag E, Fratzl P, Phipps R, Klaushofer K (2006) Effects of 3- and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women. J Bone Miner Res 21:1106\u20131112","journal-title":"J Bone Miner Res"},{"key":"9216_CR57","first-page":"77","volume-title":"The measurement of metabolic bone disease","author":"A Freemont","year":"1995","unstructured":"Freemont A (1995) Bone histomorphometry. In: Tovey F, Stamp T (eds) The measurement of metabolic bone disease. Parthenon, New York, pp 77\u201390"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-009-9216-z.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,7]],"date-time":"2019-04-07T07:07:00Z","timestamp":1554620820000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-009-9216-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,14]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["9216"],"URL":"https:\/\/doi.org\/10.1007\/s00223-009-9216-z","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,14]]}}}